Table of Contents

company-logo

IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation. It also develops INB-400 and INB-300 that is in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.

IN8bio Dividend Announcement

• IN8bio does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on IN8bio dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

IN8bio Dividend History

IN8bio Dividend Yield

IN8bio current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing IN8bio stock? Use our calculator to estimate your expected dividend yield:

IN8bio Financial Ratios

P/E ratio-0.47
PEG ratio-0.00
P/B ratio1.10
ROE-173.12%
Payout ratio0.00%
Current ratio2.66
Quick ratio2.66
Cash Ratio2.15

IN8bio Dividend FAQ

Does IN8bio stock pay dividends?
IN8bio does not currently pay dividends to its shareholders.
Has IN8bio ever paid a dividend?
No, IN8bio has no a history of paying dividends to its shareholders. IN8bio is not known for its dividend payments.
Why doesn't IN8bio pay dividends?
There are several potential reasons why IN8bio would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will IN8bio ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While IN8bio has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is IN8bio a dividend aristocrat?
IN8bio is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is IN8bio a dividend king?
IN8bio is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is IN8bio a dividend stock?
No, IN8bio is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy IN8bio stocks?
To buy IN8bio you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy IN8bio stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.